About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

CNIO Study Chosen as Most Important Discovery in Regenerative Medicine

by Savitha C Muppala on December 14, 2013 at 11:47 PM
 CNIO Study Chosen as Most Important Discovery in Regenerative Medicine

The prestigious journal Nature Medicine has taken a look at the year and chosen one of the Spanish National Cancer Research Centre's (CNIO) studies as the most important in the stem cell category for its special December edition. The edition highlights eight categories, including, as well as stem cells, immunology, cardiovascular disease or neuroscience.

The study in question, led by Manuel Serrano, the director of CNIO's Molecular Oncology Programme, was published last September in the journal Nature with the title Reprogramming in vivo produces teratomas and iPSCs with totipotency features.

Advertisement

The most important milestone achieved by the research was demostrating that cells from a variety of tissues, such as that of intestine, stomach, kidney or pancreas, can be turned into embryonic stem cells. To do so, CNIO researchers used the technique developed by the scientist Shinya Yamanaka (2012 Nobel Prize for Medicine) to obtain embryonic stem cells in vitro.

"Being able to apply this technique directly to tissues from living organisms was a big surprise, as it was thought in vivo conditions would not allow for this extent of cellular plasticity", says Serrano.
Advertisement

The journal Nature Medicine highlights that: "The significance of this work goes beyond the generation of a mouse with reprogrammable tissue", adding that "stem cells created in vivo reached a totipotent-like state and a plasticity that surpasses that of embryonic stem cells and other iPSCs made in a dish".

In this context, the cells obtained in Serrano's laboratory were even capable of forming pseudo-embryonic structures and extra-embryonic tissues such as the yolk sac.

The researchers emphasise that practical applications might yet be some way off, but admit it could change the direction of stem cell research and its applications for regenerative medicine and tissue engineering.

"The in vivo reprogramming achieved this year may bring researchers one step closer to protocols that can accomplish controlled tissue reprogramming", says the journal in its conclusion on CNIO's work.



Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest General Health News

US Woman Loses All Limbs in Fish-Related Bacterial Outbreak
In a tragic incident, a woman in the US experienced the loss of all her limbs as a result of a bacterial outbreak linked to the consumption of contaminated fish.
NIH Launches the First In-Human Universal Flu Vaccine Trial
FluMos-v2, a unique universal influenza vaccine candidate, undergoing a phase 1 trial at NIH, increases recipients' immunity against many influenza viruses.
Global Polio Eradication Initiative Assesses Vaccination Strategies in Pakistan
In Pakistan, the polio campaign focuses on more than 270,000 children under the age of five years, residing in areas with insufficient vaccine coverage.
Diagnostic Errors: The Rocky Road to Life-threatening Health Complications
Dangers of Wrong Diagnosis: Diagnostic errors in healthcare can increase the risk of permanent disabilities and deaths.
Strategies To Maintain Work-Life Balance In The Digital Age
Due to our constant connectivity and the ability to be accessible at all times, it has become challenging to separate from work and fully participate in personal life.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

CNIO Study Chosen as Most Important Discovery in Regenerative Medicine Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests